Skip to main content

Table 2 Study participants’ characteristics with bivariate and multivariable odds ratio for VIA positivity

From: Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana

Variable

All

n (%)

VIA positive

na (%)

VIA negative

na (%)

VIA positivity

BVA Odds Ratios

(95% CI)

P-value

VIA Positivity

MVA Odds

Ratios

(95% CI)

P-value for χ2 test

Age Group

5714

1959 (34.3)

3755 (65.7)

    

25–29 years

1029 (18.0)

428 (41.6)

601 (58.4)

1.47 (1.28, 1.69)

 < 0.001b

1.48 (1.28, 1.72)

 < 0.001b

30–49 years

4685 (82.0)

1531 (32.7)

3154 (67.3)

Ref

   

Smoker

5661

1937 (34.2)

3724 (65.8)

    

No

5376 (94.1)

1825 (33.9)

3551 (66.1)

Ref

   

Yes

285 (5.0)

112 (39.3)

173 (60.7)

1.27 (1.00, 1.62)

0.053

1.14 (0.89, 1.46)

0.31

Missing

53 (0.9)

      

Age sexual debut

5689

1950 (34.3)

3739 (65.7)

    

 ≤ 18

3150 (55.1)

1075 (34.1)

2075 (65.9)

0.99 (0.88, 1.10)

0.79

N/A

N/A

 > 18

2539 (44.4)

875 (34.5)

1664 (65.5)

Ref

   

Missing

25 (0.5)

      

Parity

5612

1924 (34.3)

3688 (65.7)

    

 ≤ 2

3223 (56.40)

1151 (35.7)

2072 (64.3)

Ref

   

 > 2

2389 (41.81)

773 (32.4)

1616 (67.6)

0.86 (0.77, 0.96)

0.009b

0.88 (0.79, 0.99)

0.04b

Missing

102 (1.79)

      

HIV status

5583

1941 (34.8)

3642 (65.2)

    

Negative

557 (9.74)

134 (24.1)

423 (75.9)

Ref

   

Positive

5026 (87.96)

1807 (35.9)

3219 (64.1)

1.77 (1.45, 2.17)

 < 0.001b

1.85 (1.51, 2.28)

 < 0.001b

Missing

131 (2.30)

      

CD4 Count at HIV

4475

1620 (36.2)

2855 (63.8)

    

Diagnosisc

2308 (45.9)

809 (35.1)

1499 (64.9)

0.90 (0.80, 1.02)

0.10

0.96 (0.83, 1.10)

0.52

 ≤ 350

2167 (43.1)

811 (37.4)

1356 (62.6)

Ref

   

 > 350

551 (11.0)

      

Missing

       

ART at time of screening c

4766

1710 (35.9)

3056 (64.1)

    

No

3138 (62.4)

1096 (34.9)

2047 (65.1)

0.89 (0.78, 1.00)

0.06

0.91 (0.78, 1.05)

0.19

Yes

1628 (32.4)

614 (37.7)

1014 (62.3)

Ref

   

Missing

260 (5.2)

      
  1. ART, anti-retroviral therapy; BVA, bivariate analysis; MVA, multivariate analysis; VIA, visual inspection after acetic acid
  2. aThe number of women in levels of categorical variable may not add up to total “n” because missing category has been removed
  3. bFor P < 0.05
  4. cFor HIV positive patients only